NasdaqGS:PGNYHealthcare
Why Progyny (PGNY) Is Up 7.6% After Raising 2025 Revenue and Earnings Guidance
Progyny, Inc. recently reported stronger-than-expected second quarter results and raised its full-year 2025 revenue and earnings guidance, projecting annual revenue of US$1.24 billion to US$1.27 billion and net income of US$52.3 million to US$58.9 million.
Excluding the impact of a transitioning large client, the company's outlook highlights robust underlying growth, driven by expanding demand for its fertility and women’s health benefits.
We'll explore how Progyny's upgraded guidance,...